Jafron Biomedical Co.,Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300529
  • 1d-0.13%
  • 1w4.52%
  • 1m-1.91%
  • 1y-24.95%
ATH
  • ATH Price$97.51
  • ATH Date2021-05-20
  • % since ATH-76.31%
  • % to ATH322.14%
ATL
  • ATL Price$7.54
  • ATL Date2016-08-02
  • % from ATL206.23%
  • Last Low Price$16.6
  • Last Low Date2024-02-05
  • % From Last Low39.16%
IPO
  • IPO Price$12.96
  • % Current ROI USD178.24%
  • ATH Price$97.51
  • % ROI ATH 129,271.42%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300529"]

Key Data [addtoany]

Current price $23.1
Sector Healthcare
Industry Medical Devices
Today's High/Low $23.77/$22.84
Volume 6,488,661.00
Previous Close $23.13
52 Week High/Low $31.1234/$15.88
Market Cap 18,686,822,400.00
P/E Ratio 42.0727
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $1.06
Annualized Dividend $0.0293
$23.1
[addtoany]

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biomaterials and medical devices in China.
It offers solutions for kidney, liver, critical, and rheumatoid immune diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as disinfectants, online hemodialysis B powder bags/buckets, hemodialysis concentrates, PGA absorbable sutures with needles, and resin bandages.
The company offers its products in Germany, Austria, Greece, Turkey, Vietnam, India, Thailand, Iran, Malaysia, Bangladesh, Bulgaria, the Philippines, Sweden, Uganda, Ethiopia, and internationally. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity